Curr Opin Endocrinol Diabetes Obes (2020) 27:35863
Contraception and HRT prescribing in patients on GLP-1 agonist weight-loss drugs GP with an interest in womens health Dr Toni Hazell discusses the recent rise in the use of injectable GLP-1 receptor agonists for weight loss and the challenges this can pose when prescribing contraception or HRT GLP-1 agonists arent widely available on the NHS, so why is this a big issue
Pairings are common in clinics because procedures can send a stronger collagen signal than serum alone, and then home care keeps the signal steady
Heres a list of potential side effects and considerations to monitor: Increased Hunger: This is the most consistent and potent effect, requiring diligent dietary control
Intermittent claudication is the result of hardening of the arteries (atherosclerosis)
At low doses, it temporarily blocks opioid receptors for a few hours, typically overnight, causing the brain to compensate by producing a surge of its own endogenous endorphins and enkephalins